CDC25B-IN-1

CAS No. 2374831-10-2

CDC25B-IN-1( ethyl 3-[(3-methoxynaphthalen-1-yl)amino]benzoate )

Catalog No. M26096 CAS No. 2374831-10-2

CDC25B-IN-1 is an inhibitor of CDC25B with a Ki of 8.5 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 Get Quote
10MG 410 Get Quote
25MG 678 Get Quote
50MG 954 Get Quote
100MG 1287 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CDC25B-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    CDC25B-IN-1 is an inhibitor of CDC25B with a Ki of 8.5 μM.
  • Description
    CDC25B-IN-1 is an inhibitor of CDC25B with a Ki of 8.5 μM. CDC25B-IN-1 increases the G2/M phase by inhibiting cell proliferation and colony formation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ethyl 3-[(3-methoxynaphthalen-1-yl)amino]benzoate
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phosphatase
  • Recptor
    P2X7
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2374831-10-2
  • Formula Weight
    321.376
  • Molecular Formula
    C20H19NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (311.17 mM)
  • SMILES
    CCOC(=O)c1cccc(Nc2cc(OC)cc3ccccc23)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.McGaraughty S, et al. P2X7-related modulation of pathological nociception in rats. Neuroscience. 2007 Jun 8;146(4):1817-28.
molnova catalog
related products
  • DA-3003-1

    DA-3003-1 (DA-3003-1) is a membrane-permeable, potent and selective Cdc25 dual specificity phosphatase inhibitor with antitumor activity that inhibits Cdc25B2, Cdc25A, Cdc25B2 and Cdc25C.

  • h-NTPDase-IN-4

    h-NTPDase-IN-4 is a pan-inhibitor of NTPDase, which can inhibit h-NTPDase1, 1h-NTPDase2, h-NTPDase3, h-NTPDase8. The IC50 values were 3.58 μM, 10.21 μM, 0.13 μM and 13.57 μM, respectively.

  • CPDA

    CPDA is a new potent inhibitor of SH2 domain-containing inositol phosphatase 2 (SHIP2).